This study introduces a multimodal pipeline that combines cognitive tests and MRI data from ADNI and PPMI to examine Parkinson's and Alzheimer's diseases. Using FastSurfer for quick brain volume analysis, it uncovers common neurobiological mechanisms and patterns of cognitive decline. Early findings support longitudinal multimodal evaluation, advancing precision medicine and personalized clinical decision-making in neurodegenerative disorders.